# Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia

> **NCT01781117** · NA · COMPLETED · sponsor: **KYU-SUNG LEE** · enrollment: 184 (actual)

## Conditions studied

- Benign Prostatic Hypertrophy With Outflow Obstruction
- Overactive Detrusor

## Interventions

- **PROCEDURE:** Holmium Laser Enucleation of the Prostate (HoLEP)
- **DEVICE:** Holmium laser enucleation system and morcellator

## Key facts

- **NCT ID:** NCT01781117
- **Lead sponsor:** KYU-SUNG LEE
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-11
- **Final completion:** 2017-01
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2019-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781117, "Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01781117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*